Ticker > Company >

Dr. Agarwal''s Health share price

Dr. Agarwal''s Health Care Ltd.

  42.16 K   10   3 NSE: AGARWALEYE BSE: 544350 SECTOR: Hospital & Healthcare Services

509.55
-10.35 (-1.99%)
BSE: Today, 09:05 AM

Price Summary

Today's High

₹ 0

Today's Low

₹ 0

52 Week High

₹ 567.8

52 Week Low

₹ 402.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

16154.07 Cr.

Enterprise Value

16152 Cr.

No. of Shares

31.7 Cr.

P/E

351.1

P/B

8.09

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  62.96

CASH

73.28 Cr.

DEBT

71.21 Cr.

Promoter Holding

32.34 %

EPS (TTM)

₹  1.45

Sales Growth

23.9%

ROE

2.02 %

ROCE

6.83%

Profit Growth

79.89 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year23.9%
3 Year29.35%
5 Year40.98%

Profit Growth

1 Year79.89%
3 Year7.69%
5 Year22.24%

ROE%

1 Year2.02%
3 Year2.03%
5 Year2.74%

ROCE %

1 Year6.83%
3 Year8.35%
5 Year8.61%

Debt/Equity

0.036

Price to Cash Flow

50.37

Interest Cover Ratio

1.8254

CFO/PAT (5 Yr. Avg.)

8.48868464406486

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 32.34 0.00
Mar 2026 32.36 0.00
Dec 2025 32.39 0.00
Sep 2025 32.42 0.00
Jun 2025 32.42 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 29.3487282014266% for the Past 3 years.
  • The company has significantly decreased its debt by 74.01 Cr.
  • Company is virtually debt free.
  • The Company has been maintaining an effective average operating margins of 24.7437% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -246.3665 days.
  • The company has a good cash flow management; CFO/PAT stands at 8.48868464406486.

 Limitations

  • The company has shown a poor profit growth of 7.6876237537463% for the Past 3 years.
  • Company has a poor ROE of 2.0309% over the past 3 years.
  • The company is trading at a high PE of 351.1.
  • The company is trading at a high EV/EBITDA of 45.7921.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 301.72 308.98 334.84 347.86 382.62
Total Expenditure 234.92 240.12 254.8 255.99 287.05
Operating Profit 66.8 68.86 80.04 91.87 95.57
Other Income 13.03 6.81 7.11 6.21 3.42
Interest 19.32 17.29 17.77 18.66 18.96
Depreciation 44.21 48.1 48.27 56.1 57.53
Exceptional Items -0.71 -0.72 -0.71 -4.91 0
Profit Before Tax 15.59 9.56 20.4 18.41 22.5
Tax 5.48 4.88 6.34 7.81 5.83
Profit After Tax 10.11 4.68 14.06 10.6 16.67
Adjusted EPS (Rs) 0.32 0.15 0.44 0.33 0.53

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 361.59 597.64 835.06 1043.89 1293.39
Total Expenditure 275.46 438.05 615.02 802.73 986.3
Operating Profit 86.13 159.59 220.04 241.16 307.09
Other Income 10.37 19.85 51.21 61.4 38.09
Interest 38.16 64.32 87.95 93.95 77.49
Depreciation 59.29 91.76 129.35 156.01 196.68
Exceptional Items 0 -29.2 -9.29 -14 -7.05
Profit Before Tax -0.95 -5.84 44.66 38.6 63.96
Tax 0.52 -37.43 20.83 16.67 24.51
Net Profit -1.47 31.59 23.83 21.93 39.45
Adjusted EPS (Rs.) -0.07 1.33 0.85 0.69 1.25

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 6.86 7.93 9.36 31.59 31.68
Total Reserves 192.05 553.63 1217.85 1902.05 1959.63
Borrowings 228.14 266.09 261.9 71.54 62.7
Other N/C liabilities 149.09 307.63 402.61 488.49 621.7
Current liabilities 116.31 213.3 276.94 341.84 308.69
Total Liabilities 692.45 1348.58 2168.66 2835.51 2984.4
Assets
Net Block 367.15 906.94 1302.12 1591.3 1922.28
Capital WIP 1.85 35.08 8.56 15.81 29.33
Intangible WIP 0 0 0 2.17 0
Investments 147.41 153.66 158.1 478.19 554.44
Loans & Advances 53.14 52.23 69.65 69.21 120.48
Other N/C Assets 0 0 0 52.06 50.92
Current Assets 122.9 200.67 630.23 626.77 306.95
Total Assets 692.45 1348.58 2168.66 2835.51 2984.4
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations -0.95 -5.84 44.66 38.6 63.96
Adjustment 91.98 174.65 188.2 227.23 267.57
Changes in Assets & Liabilities -9.94 -3.84 1.69 -66.46 20.76
Tax Paid -2.79 -12.28 -12.97 6.34 -31.57
Operating Cash Flow 78.3 152.69 221.58 205.71 320.72
Investing Cash Flow -98.43 -435.57 -817.6 -577.46 -166.86
Financing Cash Flow 40.16 315.94 570.41 374.08 -172.61
Net Cash Flow 20.03 33.06 -25.61 2.33 -18.75

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 32.42 32.42 32.39 32.36 32.34
a urmila 0.24 0.24 0.24 0.23 0.23
adil agarwal 4.61 4.61 4.44 4.43 4.43
adil agarwal, anosh agarw... 4.28 4.28 4.28 4.27 4.27
amar agarwal 4.95 4.95 4.46 4.45 4.45
anosh agarwal 5.84 5.84 5.83 4.23 4.23
ashar agarwal 0.94 3.28 4.46 4.45 4.45
ashvin agarwal 4.76 4.76 4.46 4.45 4.45
athiya agarwal 5.20 2.87 2.86 4.45 4.45
farah agarwal 0.24 0.24 - - -
PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 67.58 67.58 67.61 67.64 67.66
arvon investments pte.ltd... - 9.89 9.88 9.87 9.87
axis max life insurance l... - - 1.30 1.31 1.06
claymore investments (mau... 10.22 - 10.21 10.19 10.19
franklin templeton invest... - - - 1.14 1.14
government of singapore 6.48 6.48 6.47 6.42 6.35
hyperion investments pte.... - 23.15 23.13 23.10 23.09
invesco india flexi cap f... - 2.49 2.46 2.92 3.02
monetary authority of sin... 1.01 - 1.01 1.01 1.11
motilal oswal s&p bse hea... - - - - 1.47
polar capital funds plc -... 2.45 1.62 1.62 1.62 1.62
motilal oswal nifty small... - - 1.57 1.40 -
axis max life insurance l... - 1.33 - - -
claymore investments (mau... - 10.22 - - -
monetory authority of sin... - 1.01 - - -
motilal oswal nifty 500 e... - 1.48 - - -
arvon investments pte. lt... 9.89 - - - -
hyperion investments pte.... 23.15 - - - -
invesco india midcap fund... 1.36 - - - -
motilal oswal small cap f... 1.84 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Dr. Agarwal's Health Care’s arm launches world's first Pinhole Pupilloplasty Centre at Chennai 27 Aug, 4:58 PM Dr. Agarwals Health Care informs about SAST 25 Aug, 4:55 PM Dr. Agarwals Health Care informs about SAST 14 Aug, 2:21 PM Dr. Agarwals Health Care informs about SAST updates 14 Aug, 1:35 PM Dr. Agarwals Health Care informs about SAST disclosure 14 Aug, 12:48 PM Dr. Agarwal's Health - Quaterly Results 5 Aug, 12:00 AM Dr. Agarwals Health Care informs about trading window closure 20 Jun, 4:09 PM Dr. Agarwal's Health Care’s arm invests $2,00,000 in Orbit Health Care ETH 27 May, 12:09 PM Dr. Agarwal's Health - Quaterly Results 22 May, 12:00 AM Dr. Agarwals Health Care informs about updates 15 May, 1:12 PM Dr. Agarwals Health Care informs about disclosures 7 Mar, 3:54 PM Dr. Agarwals Health Care informs about disclosure 27 Feb, 12:56 PM Dr. Agarwals Health Care informs about updates 7 Feb, 11:05 AM Dr Agarwals Health Care informs about disclosure 6 Dec, 3:36 PM Dr. Agarwals Health Care informs about investor presentation 31 Oct, 1:48 PM Dr. Agarwal's Health completes acquisition of 12.25% equity share capital in AJEHPL 9 Oct, 11:52 AM Dr. Agarwal’s Health Care informs about monitoring agency report 14 Aug, 4:35 PM Dr. Agarwal's Health - Quaterly Results 12 Aug, 6:03 PM Dr. Agarwal's Health - Quaterly Results 12 Aug, 6:03 PM Dr. Agarwal's Health - Quaterly Results 28 May, 8:43 PM Dr. Agarwal's Health - Quaterly Results 28 May, 8:43 PM Dr. Agarwals Health Care informs about updates 27 May, 2:42 PM Dr. Agarwal's Health Care expands operations in New Delhi 27 May, 12:16 PM Dr. Agarwals Health Care commences operations of new branch in Andhra Pradesh 28 Mar, 11:20 AM Dr. Agarwal's Health Care commences operation of new branch 24 Mar, 5:44 PM Dr. Agarwals Health Care informs about commencement of operations of new branch 10 Mar, 5:05 PM Dr. Agarwal's Health Care’s arm inaugurates new secondary eye care center in Mysore 6 Mar, 2:51 PM Dr. Agarwal’s Health Care informs about commencement of operation of new branches 6 Mar, 12:44 PM Dr. Agarwal’s Health Care informs about commencement of operation of new branch 24 Feb, 3:23 PM Dr. Agarwal’s Health Care informs about investor presentation 17 Feb, 10:07 AM Dr. Agarwal's Health Care reports 25% jump in Q3 consolidated net profit 15 Feb, 12:47 PM Dr. Agarwal's Health - Quaterly Results 14 Feb, 7:08 PM Dr. Agarwal's Health - Quaterly Results 14 Feb, 7:08 PM Dr. Agarwal's Health Care coming with IPO to raise Rs 3043 crore 28 Jan, 1:04 PM Dr Agarwal's Health Care gets SEBI's nod for IPO 9 Jan, 12:44 PM

Dr. Agarwal''s Health Stock Price Analysis and Quick Research Report. Is Dr. Agarwal''s Health an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Dr. Agarwal''s Health. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Dr. Agarwal''s Health has a PE ratio of 357.954936953076 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Dr. Agarwal''s Health has ROA of 1.3557% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Dr. Agarwal''s Health has a Current ratio of 0.9944.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Dr. Agarwal''s Health has a ROE of 2.0216%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Dr. Agarwal''s Health has a Debt to Equity ratio of 0.036 which means that the company has low proportion of debt in its capital.

  • Sales growth: Dr. Agarwal''s Health has reported revenue growth of 23.901% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Dr. Agarwal''s Health for the current financial year is 23.7430318774693%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Dr. Agarwal''s Health is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Dr. Agarwal''s Health is Rs 1.4513. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Dr. Agarwal''s Health in Ticker for free. Also, one can get the intrinsic value of Dr. Agarwal''s Health by using Valuation Calculators, which are available with a Finology ONE subscription. 

Dr. Agarwal''s Health FAQs

Q1. What is Dr. Agarwal''s Health share price today?
Ans: The current share price of Dr. Agarwal''s Health is Rs 519.5.

Q2. What is the market capitalisation of Dr. Agarwal''s Health?
Ans: Dr. Agarwal''s Health has a market capitalisation of Rs 16469.51020685 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Dr. Agarwal''s Health?
Ans: The PE ratio of Dr. Agarwal''s Health is 357.954936953076 and the P/B ratio of Dr. Agarwal''s Health is 8.25170315470792, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Dr. Agarwal''s Health share?
Ans: The 52-week high share price of Dr. Agarwal''s Health is Rs 568, and the 52-week low share price of Dr. Agarwal''s Health is Rs 401.

Q5. Does Dr. Agarwal''s Health pay dividends?
Ans: Currently, Dr. Agarwal''s Health does not pay dividends. Dividend yield of Dr. Agarwal''s Health is around 0%.

Q6. What are the face value and book value of Dr. Agarwal''s Health shares?
Ans: The face value of Dr. Agarwal''s Health shares is Rs 1, while the book value per share of Dr. Agarwal''s Health is around Rs 62.9567. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Dr. Agarwal''s Health?
Ans: Dr. Agarwal''s Health has a total debt of Rs 71.21 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Dr. Agarwal''s Health?
Ans: The ROE of Dr. Agarwal''s Health is 2.0216% and ROCE of Dr. Agarwal''s Health is 6.8311%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Dr. Agarwal''s Health a good buy for the long term?
Ans: The Dr. Agarwal''s Health long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Dr. Agarwal''s Health undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Dr. Agarwal''s Health appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Dr. Agarwal''s Health’s financials?
Ans: You can review Dr. Agarwal''s Health’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Dr. Agarwal''s Health
X